A method for analyzing related substances of sunitinib malate

A technology for sunitinib malate and related substances, which is applied in the field of optimized detection of chemical raw material sunitinib malate related substances, and can solve the problems of low accuracy, poor specificity, low efficiency and the like

Inactive Publication Date: 2016-06-01
SUNSHINE LAKE PHARM CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore described method exists specificity difference, accuracy is low and operation time is too long, the problem of low efficiency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for analyzing related substances of sunitinib malate
  • A method for analyzing related substances of sunitinib malate
  • A method for analyzing related substances of sunitinib malate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] The related substance analysis method of sunitinib malate crude drug provided by the invention is characterized in that:

[0026] The method is carried out on a high performance liquid chromatograph;

[0027] The detector is a diode array detector (DAD) or an ultraviolet absorption detector (UV), and the detection wavelength is 268nm;

[0028] The liquid chromatographic column is Poroshell120BonusRP reversed-phase chromatographic column, and the temperature of the chromatographic column is 20℃~30℃;

[0029] The mobile phase is composed of ammonium acetate aqueous solution as a buffer and acetonitrile as an organic solvent, and is subjected to gradient elution, and the flow rate of the mobile phase is about 0.9mL / min~1.1mL / min;

[0030] Inject sunitinib malate test solution and sunitinib malate reference solution for detection, and calculate the content of related substances according to the principal component self-control method without correction factor.

[0031] In...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
wavelengthaaaaaaaaaa
lengthaaaaaaaaaa
Login to view more

Abstract

The invention relates to a method for analyzing substances relevant to sunitinib malate. The method is carried out on a high performance liquid chromatography; a Poroshell120 Bonus RP chromatographic column is adopted; an ammonium acetate aqueous solution and an organic solvent-acetonitrile act as flow phases; a liquid phase diode array detector (DAD) or an ultraviolet (UV) detector are used for performing gradient elution detection; a relevant substance B, a relevant substance C, a relevant substance E and other relevant substances are separated and detected effectively. The method has the characteristics of good specificity, high accuracy, easiness, convenience and rapidness.

Description

technical field [0001] The invention relates to the field of medicine and chemical industry, and more specifically relates to an optimized method for detecting related substances of sunitinib malate, a chemical raw material drug. Background technique [0002] Sunitinib malate, chemical name N-(2-diethylaminoethyl)-5[(Z)-(5-fluoro-2-oxo-1hydro-indole-3-ylidene)methyl ]-2,4-dimethyl-1 hydrogen-pyrrole-3-carboxamide malate, its chemical structure is: [0003] [0004] It is a multi-target receptor tyrosine kinase (RTK) inhibitor, which is mainly used for the treatment of gastrointestinal stromal tumors and metastatic renal cell carcinoma that do not respond to or cannot tolerate standard therapy through oral administration. The drug has been approved for marketing by the US FDA and the European EMEA, and the product is Sutent. Chinese authorized patent CN1329390C discloses a preparation method of sunitinib malate. [0005] Usually, sunitinib malate raw materials also cont...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02
Inventor 杨成栾保磊刘国柱
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap